We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Reaction of Investigational Drugs to Acid-Reducing Agents Should Be Studied, Guidance Says
Reaction of Investigational Drugs to Acid-Reducing Agents Should Be Studied, Guidance Says
Sponsors of drug trials should determine what effect the use of acid-reducing agents (ARA), such as antacids, proton pump inhibitors and histamine blockers, could have on the solubility of an orally administered drug, according to a new FDA draft guidance released Monday.